Skip to content
The Policy VaultThe Policy Vault

Thiola ECMedica

severe homozygous cystinuria for the prevention of cystine kidney stone formation in adults and pediatric patients ≥ 20 kg who are not responsive to conservative measures (high fluid intake, alkali, and diet modification) alone

Preferred products

  • generic tiopronin delayed-release tablets
  • generic tiopronin tablets
  • Venxxiva tablets

Initial criteria

  • Patient meets the standard Prior Authorization Policy criteria for tiopronin products
  • Patient has tried one Preferred Product (generic tiopronin delayed-release tablets, generic tiopronin tablets, or Venxxiva tablets)

Approval duration

per Metabolic Disorders – Tiopronin Products Prior Authorization Policy